Aveanna Healthcare (NASDAQ:AVAH) CFO Matthew Buckhalter Sells 18,340 Shares

by · The Markets Daily

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) CFO Matthew Buckhalter sold 18,340 shares of the company’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $7.85, for a total value of $143,969.00. Following the sale, the chief financial officer owned 436,980 shares of the company’s stock, valued at $3,430,293. This represents a 4.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Matthew Buckhalter also recently made the following trade(s):

  • On Wednesday, December 31st, Matthew Buckhalter sold 17,289 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total value of $141,424.02.
  • On Tuesday, December 30th, Matthew Buckhalter sold 17,448 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total value of $145,865.28.

Aveanna Healthcare Trading Down 1.1%

AVAH traded down $0.09 on Friday, reaching $8.08. 2,526,966 shares of the company’s stock were exchanged, compared to its average volume of 1,076,101. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.67 and a twelve month high of $10.32. The company’s 50 day moving average is $8.92 and its 200-day moving average is $7.49. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The company has a market cap of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06.

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. The firm had revenue of $450.53 million for the quarter. Equities analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on AVAH. Raymond James Financial reiterated an “outperform” rating and issued a $13.00 price target on shares of Aveanna Healthcare in a report on Friday, December 5th. Jefferies Financial Group boosted their price objective on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. JPMorgan Chase & Co. upgraded Aveanna Healthcare from an “underweight” rating to a “neutral” rating and raised their target price for the company from $6.00 to $10.00 in a report on Thursday, September 18th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday. Five analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $10.69.

Get Our Latest Report on Aveanna Healthcare

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Summit Partners L P acquired a new stake in Aveanna Healthcare during the 2nd quarter valued at approximately $50,477,000. Vanguard Group Inc. raised its position in shares of Aveanna Healthcare by 34.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock valued at $35,850,000 after purchasing an additional 1,041,324 shares in the last quarter. AustralianSuper Pty Ltd purchased a new position in shares of Aveanna Healthcare during the 3rd quarter valued at approximately $15,743,000. Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Aveanna Healthcare by 70.1% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,130,912 shares of the company’s stock worth $10,031,000 after buying an additional 466,022 shares in the last quarter. Finally, Algert Global LLC grew its position in shares of Aveanna Healthcare by 120.1% during the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock worth $9,070,000 after buying an additional 557,898 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

Read More